Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/32364 |
Resumo: | OBJECTIVE: To describe the profile of injecting drug users living with HIV/AIDS and estimate hepatitis B and hepatitis C prevalence rates within this group. METHODS: Cross-sectional study conducted with 205 injecting drug users living with HIV/AIDS receiving attention in three public health clinics in the city of Sao Paulo, in 2003. A non-probabilistic sample of volunteers was selected consecutively on the days respondents appeared for their appointments at the clinics. Personal data and information on sexual behavior, drug use and knowledge of hepatitis was collected through interviews. Tests were conducted to detect infections of the hepatitis B and C viruses. RESULTS: Out of the interviewees, 81% were men and 19% women, with an average age of 39 (SD = 6.1) and six years of formal education (SD = 2.0). There was no difference in marital status between the sexes, of which 48% were single, 42% were married, and 8% were divorced. The average ages for first use of tobacco, alcohol and illegal drugs were 13, 15 and 18, respectively. Hepatitis B and C prevalence were 55% (95% CI: 49;63) and 83%(95% CI: 78;88), respectively. Eighty percent of respondents had not heard of Hepatitis B and C prior to the first time they used injecting drugs. CONCLUSIONS: The high prevalence rates of Hepatitis B and C and low level of knowledge regarding the diseases justify the inclusion of information about hepatitis infections and the hepatitis B vaccines in HIV harm reduction strategies. |
id |
USP-23_03054c76cae0c68facb4a9a48903587d |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/32364 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil Hepatitis C^i2^sepidemiolHepatitis C^i2^sprevention & contHepatitis B^i2^sepidemiolHepatitis B prevention & controlHIV infections^i2^sepidemiolSubstance abuse^i2^sIntravenCross-sectional studiesHepatite C^i1^sepidemioloHepatite C^i1^sprevenção e contrHepatite B^i1^sepidemioloHepatite B^i1^sprevenção e contrnfecções por HIV^i1^sepidemioloAbuso de substâncias por via intravenosaEstudos transversais OBJECTIVE: To describe the profile of injecting drug users living with HIV/AIDS and estimate hepatitis B and hepatitis C prevalence rates within this group. METHODS: Cross-sectional study conducted with 205 injecting drug users living with HIV/AIDS receiving attention in three public health clinics in the city of Sao Paulo, in 2003. A non-probabilistic sample of volunteers was selected consecutively on the days respondents appeared for their appointments at the clinics. Personal data and information on sexual behavior, drug use and knowledge of hepatitis was collected through interviews. Tests were conducted to detect infections of the hepatitis B and C viruses. RESULTS: Out of the interviewees, 81% were men and 19% women, with an average age of 39 (SD = 6.1) and six years of formal education (SD = 2.0). There was no difference in marital status between the sexes, of which 48% were single, 42% were married, and 8% were divorced. The average ages for first use of tobacco, alcohol and illegal drugs were 13, 15 and 18, respectively. Hepatitis B and C prevalence were 55% (95% CI: 49;63) and 83%(95% CI: 78;88), respectively. Eighty percent of respondents had not heard of Hepatitis B and C prior to the first time they used injecting drugs. CONCLUSIONS: The high prevalence rates of Hepatitis B and C and low level of knowledge regarding the diseases justify the inclusion of information about hepatitis infections and the hepatitis B vaccines in HIV harm reduction strategies. OBJETIVO: Descrever o perfil de usuários de drogas injetáveis vivendo com HIV/Aids e estimar a prevalência de hepatites B e C nesse grupo. MÉTODOS: Estudo transversal realizado com 205 pessoas vivendo com HIV/Aids, usuários de drogas injetáveis em acompanhamento em três unidades de atendimento da rede pública do Município de São Paulo, em 2003. Foi selecionada amostra não-probabilística, obtida de forma consecutiva e voluntária, nos dias em que compareciam para consulta nas unidades de atendimento. Por meio de entrevistas, foram levantados dados pessoais e informações sobre comportamento sexual, uso de drogas e conhecimento de hepatites. Foram realizados testes para detecção da infecção pelos vírus das hepatites B e C. RESULTADOS: Dos entrevistados, 81% eram homens e 19% mulheres, com idade média de 39 anos (dp=6,1) e seis anos de educação formal (dp=2,0). Não havia diferença em relação ao estado marital entre os sexos, 48% eram solteiros, 42% casados e 8% divorciados. A idade média do primeiro uso de tabaco, álcool e drogas ilícitas foi 13, 15 e 18 anos, respectivamente. Prevalências de hepatites B e C foram, respectivamente, de 55% (IC 95%: 49;63) e 83% (IC 95%: 78;88). Antes de usar droga injetável pela primeira vez, 80% dos respondentes não tinham ouvido falar de hepatites B e C. CONCLUSÕES: A alta prevalência de hepatites B e C e o baixo nível de conhecimento sobre a doença justificam a inclusão de esclarecimentos sobre as infecções hepáticas e de vacinação contra hepatite B nas estratégias de redução de danos pelo HIV. Universidade de São Paulo. Faculdade de Saúde Pública2007-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/3236410.1590/S0034-89102007000900010Revista de Saúde Pública; Vol. 41 No. suppl.2 (2007); 57-63 Revista de Saúde Pública; Vol. 41 Núm. suppl.2 (2007); 57-63 Revista de Saúde Pública; v. 41 n. suppl.2 (2007); 57-63 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPporenghttps://www.revistas.usp.br/rsp/article/view/32364/34559https://www.revistas.usp.br/rsp/article/view/32364/34560Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessMarchesini, Angela MattosPrá-Baldi, Zilá PrestesMesquita, FábioBueno, ReginaBuchalla, Cássia Maria2012-07-09T00:49:09Zoai:revistas.usp.br:article/32364Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-07-09T00:49:09Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil |
title |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
spellingShingle |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil Marchesini, Angela Mattos Hepatitis C^i2^sepidemiol Hepatitis C^i2^sprevention & cont Hepatitis B^i2^sepidemiol Hepatitis B prevention & control HIV infections^i2^sepidemiol Substance abuse^i2^sIntraven Cross-sectional studies Hepatite C^i1^sepidemiolo Hepatite C^i1^sprevenção e contr Hepatite B^i1^sepidemiolo Hepatite B^i1^sprevenção e contr nfecções por HIV^i1^sepidemiolo Abuso de substâncias por via intravenosa Estudos transversais |
title_short |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
title_full |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
title_fullStr |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
title_full_unstemmed |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
title_sort |
Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil |
author |
Marchesini, Angela Mattos |
author_facet |
Marchesini, Angela Mattos Prá-Baldi, Zilá Prestes Mesquita, Fábio Bueno, Regina Buchalla, Cássia Maria |
author_role |
author |
author2 |
Prá-Baldi, Zilá Prestes Mesquita, Fábio Bueno, Regina Buchalla, Cássia Maria |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Marchesini, Angela Mattos Prá-Baldi, Zilá Prestes Mesquita, Fábio Bueno, Regina Buchalla, Cássia Maria |
dc.subject.por.fl_str_mv |
Hepatitis C^i2^sepidemiol Hepatitis C^i2^sprevention & cont Hepatitis B^i2^sepidemiol Hepatitis B prevention & control HIV infections^i2^sepidemiol Substance abuse^i2^sIntraven Cross-sectional studies Hepatite C^i1^sepidemiolo Hepatite C^i1^sprevenção e contr Hepatite B^i1^sepidemiolo Hepatite B^i1^sprevenção e contr nfecções por HIV^i1^sepidemiolo Abuso de substâncias por via intravenosa Estudos transversais |
topic |
Hepatitis C^i2^sepidemiol Hepatitis C^i2^sprevention & cont Hepatitis B^i2^sepidemiol Hepatitis B prevention & control HIV infections^i2^sepidemiol Substance abuse^i2^sIntraven Cross-sectional studies Hepatite C^i1^sepidemiolo Hepatite C^i1^sprevenção e contr Hepatite B^i1^sepidemiolo Hepatite B^i1^sprevenção e contr nfecções por HIV^i1^sepidemiolo Abuso de substâncias por via intravenosa Estudos transversais |
description |
OBJECTIVE: To describe the profile of injecting drug users living with HIV/AIDS and estimate hepatitis B and hepatitis C prevalence rates within this group. METHODS: Cross-sectional study conducted with 205 injecting drug users living with HIV/AIDS receiving attention in three public health clinics in the city of Sao Paulo, in 2003. A non-probabilistic sample of volunteers was selected consecutively on the days respondents appeared for their appointments at the clinics. Personal data and information on sexual behavior, drug use and knowledge of hepatitis was collected through interviews. Tests were conducted to detect infections of the hepatitis B and C viruses. RESULTS: Out of the interviewees, 81% were men and 19% women, with an average age of 39 (SD = 6.1) and six years of formal education (SD = 2.0). There was no difference in marital status between the sexes, of which 48% were single, 42% were married, and 8% were divorced. The average ages for first use of tobacco, alcohol and illegal drugs were 13, 15 and 18, respectively. Hepatitis B and C prevalence were 55% (95% CI: 49;63) and 83%(95% CI: 78;88), respectively. Eighty percent of respondents had not heard of Hepatitis B and C prior to the first time they used injecting drugs. CONCLUSIONS: The high prevalence rates of Hepatitis B and C and low level of knowledge regarding the diseases justify the inclusion of information about hepatitis infections and the hepatitis B vaccines in HIV harm reduction strategies. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/32364 10.1590/S0034-89102007000900010 |
url |
https://www.revistas.usp.br/rsp/article/view/32364 |
identifier_str_mv |
10.1590/S0034-89102007000900010 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/32364/34559 https://www.revistas.usp.br/rsp/article/view/32364/34560 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2017 Revista de Saúde Pública info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2017 Revista de Saúde Pública |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; Vol. 41 No. suppl.2 (2007); 57-63 Revista de Saúde Pública; Vol. 41 Núm. suppl.2 (2007); 57-63 Revista de Saúde Pública; v. 41 n. suppl.2 (2007); 57-63 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221786902626304 |